Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$567M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$503M |
| 3 |
Netflix
NFLX
|
+$499M |
| 4 |
Bausch Health
BHC
|
+$323M |
| 5 |
MON
Monsanto Co
MON
|
+$314M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$967M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$840M |
| 3 |
Valero Energy
VLO
|
+$436M |
| 4 |
Capri Holdings
CPRI
|
+$368M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Communication Services | 12% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Financials | 9.77% |
| 5 | Energy | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Meta Platforms (Facebook)
META
$1.4T
| $275M | 1.2% |
4,087,288
-4,734,226
| -54% | -$291M |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $269M | 1.18% |
1,207,824
+116,280
| +11% | +$24.1M |
|
28
DaVita
DVA
$11.1B
| $252M | 1.1% |
3,489,084
+1,571,980
| +82% | +$109M |
|
|
NFX
29
DELISTED
Newfield Exploration
NFX
| $237M | 1.04% |
+5,364,990
| New | +$192M |
|
|
30
Capri Holdings
CPRI
$1.55B
| $236M | 1.03% |
2,658,573
-4,010,366
| -60% | -$368M |
|
31
Apple
AAPL
$4.51T
| $212M | 0.93% |
+9,144,712
| New | +$195M |
|
|
32
Valero Energy
VLO
$100B
| $211M | 0.92% |
4,218,837
-7,913,035
| -65% | -$436M |
|
33
Workday
WDAY
$49.4B
| $204M | 0.89% |
2,271,588
-851,961
| -27% | -$67.1M |
|
34
H&R Block
HRB
$6.62B
| $200M | 0.87% |
6,133,995
-10,919,921
| -64% | -$325M |
|
35
Cognizant
CTSH
$27.9B
| $192M | 0.84% |
+3,915,440
| New | +$191M |
|
36
Hilton Worldwide
HLT
$73.5B
| $179M | 0.78% |
+2,560,475
| New | +$170M |
|
37
Ralph Lauren
RL
$22.2B
| $168M | 0.74% |
+1,048,443
| New | +$162M |
|
|
AGN
38
DELISTED
Allergan Inc
AGN
| $136M | 0.59% |
+803,369
| New | +$125M |
|
39
Autodesk
ADSK
$53.6B
| $126M | 0.55% |
2,238,794
-3,492,842
| -61% | -$177M |
|
40
Universal Health Services
UHS
$10.4B
| $122M | 0.53% |
1,277,443
-1,482,356
| -54% | -$128M |
|
41
Acadia Pharmaceuticals
ACAD
$5.08B
| $107M | 0.47% |
4,757,878
+1,159,471
| +32% | +$24.2M |
|
42
Elevance Health
ELV
$86.9B
| $103M | 0.45% |
+954,285
| New | +$98.3M |
|
|
RAD
43
DELISTED
Rite Aid Corporation
RAD
| $96.5M | 0.42% |
+672,948
| New | +$99.3M |
|
|
ZNGA
44
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $83.2M | 0.36% |
25,926,695
-2,525,775
| -9% | -$9.14M |
|
|
PCP
45
DELISTED
PRECISION CASTPARTS CORP
PCP
| $83M | 0.36% |
+328,801
| New | +$84.1M |
|
46
Trip.com Group
TCOM
$29B
| $75.5M | 0.33% |
+2,356,926
| New | +$63.6M |
|
|
XEC
47
DELISTED
CIMAREX ENERGY CO
XEC
| $71.5M | 0.31% |
+498,700
| New | +$63.4M |
|
48
Crown Castle
CCI
$32.1B
| $68.2M | 0.3% |
918,640
-1,652,103
| -64% | -$124M |
|
|
TGI
49
DELISTED
Triumph Group
TGI
| $66.8M | 0.29% |
956,398
-2,754,793
| -74% | -$186M |
|
50
Zimmer Biomet
ZBH
$19.3B
| $62.6M | 0.27% |
+621,289
| New | +$60.6M |
|
Similar funds
Andreas Halvorsen's Q2 2014 Portfolio in Review
As of Q2 2014, Andreas Halvorsen held 80 positions worth $22.9B, down 3.9% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Andreas Halvorsen withdrew a net $2.63B in Q2 2014, closing 18 positions and reducing 25 holdings. Its most notable exit was American International, an estimated $316M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Andreas Halvorsen opened a new position in Netflix worth $580M.
- Andreas Halvorsen's largest Q2 2014 buy was Netflix: 92,226,190 shares worth $580M.
- Andreas Halvorsen added most to Regeneron Pharmaceuticals in Q2 2014, an estimated $567M increase.
- Andreas Halvorsen's biggest Q2 2014 reduction was Time Warner Inc, cutting an estimated $967M.
- Andreas Halvorsen fully exited American International in Q2 2014, selling an estimated $316M.
- Andreas Halvorsen's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2014.
- Andreas Halvorsen opened 20 new positions and closed 18 in Q2 2014.
- Andreas Halvorsen's portfolio value fell 3.9% quarter-over-quarter to $22.9B.
Based on Viking Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.